Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of 5-Aminolevulinic Acid Photodynamic Therapy for Oral Lichen Planus
2006-004696-35Phase 4Terminated
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of 5-aminolevulinic acid in oral lichen planus (OLP), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Reduced immunosuppressant use following treatment. Started Apr 2007; status: terminated.
02
Drugs
5-aminolevulinic acid
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on 2006-004696-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004696-35.